<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BIOMUNE SYSTEMS, INC. DECEMBER 31, 1998 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> SEP-30-1999 <PERIOD-END> DEC-31-1998 <CASH> 668,998 <SECURITIES> 0 <RECEIVABLES> 3,104,994 <ALLOWANCES> 145,142 <INVENTORY> 580,123 <CURRENT-ASSETS> 2,972,514 <PP&E> 280,949 <DEPRECIATION> 134,361 <TOTAL-ASSETS> 5,986,349 <CURRENT-LIABILITIES> 1,981,407 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 2,612,124 <COMMON> 134 <OTHER-SE> 1,346,320 <TOTAL-LIABILITY-AND-EQUITY> 5,986,349 <SALES> 1,161,827 <TOTAL-REVENUES> 1,161,827 <CGS> 489,892 <TOTAL-COSTS> 1,017,928 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> 174,313 <INCOME-TAX> 0 <INCOME-CONTINUING> 174,313 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 174,313 <EPS-PRIMARY> 0.09 <EPS-DILUTED> 0.05